Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.945 USD | -0.92% |
|
+7.78% | +63.74% |
06-22 | MannKind Corporation Announces Positive 17-Week Results from the INHALE-3 Study | CI |
05-29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.74% | 1.63B | |
+19.76% | 126B | |
+24.94% | 118B | |
+25.27% | 27.87B | |
-17.06% | 20.95B | |
-14.87% | 16.92B | |
-13.72% | 16.18B | |
+10.88% | 14.84B | |
-47.10% | 14.79B | |
+53.07% | 14.08B |
- Stock Market
- Equities
- MNKD Stock
- News MannKind Corporation
- Transcript : MannKind Corp. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 07